The MRI-guided neurosurgical ablation market is poised for significant growth, with projections estimating the market to reach USD 168.13 million in 2024. The market is expected to expand at a steady compound annual growth rate (CAGR) of 3.1% from 2024 to 2034, ultimately reaching USD 227.56 million by 2034.
MRI-guided neurosurgical ablation is a minimally invasive technique used to treat a variety of neurological conditions, including brain metastases, radiation necrosis, glioma, and epilepsy. Among these, drug-resistant epilepsy is the most common indication for the procedure. The technique is gaining traction due to its precision, reduced recovery time, and ability to target specific areas of the brain without the need for traditional open surgery.
Gain Access to Market Trends: Request Your Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d32353134
One of the key trends driving the growth of the market is the increasing adoption of non-cooled laser systems, which offer enhanced performance in neurosurgical procedures. As medical technology continues to evolve, the focus on improving treatment outcomes through advanced, minimally invasive methods is becoming more prominent.
Additionally, market players are actively pursuing regulatory approvals in multiple countries to expand their presence and revenue streams. This has been further bolstered by growing insurance coverage for MRI-guided neurosurgical ablation procedures, making the treatment more accessible to patients worldwide.
The combination of MRI-guided neurosurgical ablation with drug therapy is also showing promising results, offering new hope for patients with complex neurological conditions. With these advancements, the future of MRI-guided neurosurgical ablation is bright, and the market is expected to witness continued growth as the technology continues to evolve.
Key Takeaways:
- The global market size in 2023 was valued at USD 163.14 million.
- It is estimated to grow to USD 168.13 million in 2024.
- By 2034, the market is projected to reach USD 227.56 million.
- The value-based CAGR (2024 to 2034) is forecasted at 3.1%.
Regional Insights:
- USA: Projected to experience a 2.2% CAGR from 2024 to 2034
- Canada: Expected to see a 2.3% CAGR over the same period from 2024 to 2034
- Germany: Anticipated to grow at a 3.2% CAGR from 2024 to 2034
- France: Also projected to see a 3.2% CAGR from 2024 to 2034
- Italy: Forecasted to grow at a 2.8% CAGR from 2024 to 2034
- China: Expected to see a 3.9% CAGR, the highest among the listed countries from 2024 to 2034
- India: Projected to witness a robust 5.6% CAGR from 2024 to 2034
- Japan: Anticipated to experience a 3.8% CAGR from 2024 to 2034
Dive Deep into the Market Trends: Access the Full MRI Guided Neurosurgical Ablation Market Report! https://www.futuremarketinsights.com/reports/mri-guided-neurosurgical-ablation-market
Competitive Landscape of the MRI-Guided Neurosurgical Ablation Industry:
Industry leaders in the MRI-guided neurosurgical ablation market are heavily investing in research and development, continuously enhancing the functionality of their systems with each new iteration, surpassing previous models. As these procedures are expensive, market players are actively working to secure insurance coverage for MRI-guided neurosurgical procedures. This would lead to an increase in the number of procedures performed, thereby driving demand for MRI-guided neurosurgical ablation systems and boosting company revenues.
Recent Industry Developments in the MRI-Guided Neurosurgical Ablation Market:
- In May 2024, Monteris Medical announced the launch of their latest product, the NeuroBlate® NB3 FullFire® 1.6mm laser probe, designed for use with the NeuroBlate System.
- In February 2024, Anthem Blue Cross and Blue Shield (BCBS) introduced insurance coverage for the innovative focused ultrasound pallidotomy procedure, expanding their comprehensive Parkinson’s disease treatment coverage.
Key Players of the MRI Guided Neurosurgical Ablation Industry:
- Medtronic plc
- Insightec
- Monteris Medical Inc.
- ClearPoint Neuro, Inc.
Discover the Latest Healthcare Trends Today! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device
MRI Guided Neurosurgical Ablation Market Segmentation
By Product:
In terms of product, the industry is segmented into MRI guided laser therapy systems, MRI guided focused ultrasound systems, and accessories.
By Treatment Type:
In terms of treatment types, the industry is bifurcated into brain metastases, radiation necrosis, glioma, epilepsy, and other treatments.
By End User:
In terms of end use, the industry is segregated into hospitals, cancer treatment centers, specialized surgical centers (neurology and neurosurgery centers), and academic & research institutes.
By Region:
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, the Middle East, and Africa have been covered in the report.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
